Premature labour precipitated by highly active antiretroviral therapy: An adverse reaction in a newly diagnosed HIV-positive patient

Sexual Health

Volumn 8, Issue 3, 2011, Pages 436-438

  Broom, Jennifer ^a   Sowden, David ^a  

^a NAMBOUR GENERAL HOSPITAL   (Australia)

Author keywords

highly active antiretroviral therapy; pregnancy; preterm birth; zidovudine

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIARRHYTHMIC AGENT; ASPARTATE AMINOTRANSFERASE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR;

ARTICLE; CASE REPORT; DIAGNOSTIC IMAGING; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL COUNT; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FUNCTION TEST; MACULOPAPULAR RASH; POLYMERASE CHAIN REACTION; PREGNANT WOMAN; PREMATURE LABOR; VIRUS LOAD; WESTERN BLOTTING;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DRUG ERUPTIONS; FEMALE; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS; VIRAL LOAD;

EID: 84860419248     PISSN: 14485028     EISSN: 14498987     Source Type: Journal    
DOI: 10.1071/SH10071     Document Type: Article

References (18)

1. Grosch-Woerner I, Puch K, Maier RF, Niehues T, Notheis G, Patel D, et al. Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV-1- infected women. HIV Med 2008; 9: 6-13. doi:10.1111/j.1468-1293. 2008.00520.x
2. Ravizza M, Martinelli P, Bucceri A, Fiore S, Alberico S, Tamburrini E, et al. Treatment with protease inhibitors and coinfection with hepatitis C virus are independent predictors of preterm delivery in HIV-infected pregnant women. J Infect Dis 2007; 195: 913-4, author reply 916. doi:10.1086/507045
3. European Collaborative Study; Swiss Mother and Child HIV Cohort Study. Combination antiretroviral therapy and duration of pregnancy. AIDS 2000; 14: 2913-20. doi:10.1097/00002030-200012220-00013
4. Thorne C, Patel D, Newell ML. European Collaborative Study. Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe. AIDS 2004; 18: 2337-9. doi:10.1097/00002030-200411190-00019
5. Kourtis AP, Schmid CH, Jamieson DJ, Lau J. Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis. AIDS 2007; 21: 607-15. doi:10.1097/QAD. 0b013e32802ef2f6
6. Patel K, Shapiro DE, Brogly SB, Livingston EG, Stek AM, Bardeguez AD, et al. Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy. J Infect Dis 2010; 201: 1035-44. doi:10.1086/651232
7. Kennedy JD. Lung function outcome in children of premature birth. J Paediatr Child Health 1999; 35: 516-21. doi:10.1046/j.1440-1754. 1999.00422.x
8. Chen ML, Guo L, Smith LE, Dammann CE, Dammann O. High or low oxygen saturation and severe retinopathy of prematurity: a metaanalysis. Pediatrics 1483; 125: 24.
9. Baron IS, Rey-Casserly C. Extremely preterm birth outcome: a review of four decades of cognitive research. Neuropsychol Rev 2010; 20: 430-52. doi:10.1007/s11065-010-9132-z
10. Giles ML, Pedrana A, Jones C, Garland S, Hellard M, Lewin SR. Antenatal screening practice for infectious diseases by generalpractitioners in Australia. Aust N Z J Obstet Gynaecol 2009; 49: 39-44. doi:10.1111/j.1479-828X.2008.00932. x
11. Patterson KB, Leone PA, Fiscus SA, Kuruc J, McCoy SI, Wolf L, et al. Frequent detection of acute HIV infection in pregnant women. AIDS 2007; 21: 2303-8. doi:10.1097/QAD.0b013e3282f155da
12. Coopman SA, Johnson RA, Platt R, Stern RS. Cutaneous disease and drug reactions in HIV infection. N Engl J Med 1993; 328: 1670-4. doi:10.1056/ NEJM199306103282304
13. Murri R, Antinori A, Camilli G, Zannoni G, Patriarca G. Fatal toxic epidermolysis induced by zidovudine. Clin Infect Dis 1996; 23: 640-1.
14. Torres RA, Lin RY, Lee M, Barr MR. Zidovudine-induced leukocytoclastic vasculitis. Arch Intern Med 1992; 152: 850-1. doi:10.1001/archinte.152.4.850
15. Wassef M, Keiser P. Hypersensitivity of zidovudine: report of a case of anaphylaxis and review of the literature. Clin Infect Dis 1995; 20:1387-9.
16. McKinley GF, Mazza DS, Grieco MH. Urticarial reaction to zidovudine. Lancet 1990; 336: 384. doi:10.1016/0140-6736(90) 91933-2
17. Kim SB, Seo PJ, Baik du S, Yun SY, Kim BH, Shin JE, et al. A case of severe skin eruption caused by lamivudine in a patient with chronic hepatitis B [in korean]. Korean J Gastroenterol 2006; 48: 281-5.
18. Calista D. Maculo-papular rash induced by lopinavir/ritonavir. Eur J Dermatol 2005; 15: 97-8.